Malignant priapism secondary to metastatic colon adenocarcinoma: a case report

Background and objective: Priapism is an uncommon urological emergency, and is even less commonly caused by colon adenocarcinoma metastasis. The aim of this article is to report a case of malignant priapism caused by metastatic colon adenocarcinoma.

Methods and materials: Case sharing and clinical experience summary of a 61-year-old man with priapism and hematuria persisting for more than 30 days presented to our hospital in September 2019.

Results: The patient did not have a history of perineal trauma, nervous system disease, or hematological system disease. Penile Doppler ultrasound showed no obvious blood flow signal, and penile arterial blood gas parameters were pH of 7.01, partial pressure of oxygen of 26 mmHg, and partial pressure of carbon dioxide of 71 mmHg, suggesting the occurrence of ischemic priapism. Abdominopelvic computed tomography enhancement images showed a localized irregular shape and high-density imaging of the root of the corpus cavernosum. Histopathology after cystoscopy confirmed the metastasis of colon adenocarcinoma. Superselective embolization of the internal pudendal artery was performed, which partially relieve the abnormal penile erection, but drug treatment did not significantly alleviate the patient's priapism.

Conclusion: Priapism secondary to metastatic colon adenocarcinoma suggests systemic dissem-ination, indicative of a poor prognosis. In such cases, unnecessary surgery should be avoided. Superselective embolization could be an optional treatment for priapism secondary to cancer.

Priapism; Colon adenocarcinoma; Tumor metastasis

[1] Offenbacher J, Barbera A. Penile Emergencies. Emergency Medicine Clinics of North America. 2019; 37: 583–592.

[2] Mishra K, Loeb A, Bukavina L, Baumgarten A, Beilan J, Mendez M, et al. Management of Priapism: a Contemporary Review. Sexual Medicine Reviews. 2020; 8: 131–139.

[3] Prabhuswamy VK, Krishnappa P, Tyagaraj K. Malignant refractory priapism: an urologist’s nightmare. Urology Annals. 2019; 11: 222–225.

[4] Chaux A, Amin M, Cubilla AL, Young RH. Metastatic Tumors to the Penis. International Journal of Surgical Pathology. 2011; 19: 597–606.

[5] Cocci A, Hakenberg OW, Cai T, Nesi G, Livi L, Detti B, et al. Prognosis of men with penile metastasis and malignant priapism: a systematic review. Oncotarget. 2018; 9: 2923–2930.

[6] Muneer A, Ralph D. Guideline of guidelines: priapism. BJU Interna-tional. 2017; 119: 204–208.

[7] Park JC, Lee WH, Kang MK, Park SY. Priapism secondary to penile metastasis of rectal cancer. World Journal of Gastroenterology. 2009; 15: 4209–4211.

[8] Pereira R, Perera M, Rhee H. Metastatic plasmacytoid bladder cancer causing malignant priapism. BMJ Case Reports. 2019; 12: e228088.

[9] Salonia A, Eardley I, Giuliano F, Hatzichristou D, Moncada I, Vardi Y, et al. European Association of Urology Guidelines on Priapism. European Urology. 2014; 65: 480–489.

[10] Zhao H, Dallas K, Masterson J, Lo E, Houman J, Berdahl C, et al. Risk Factors for Surgical Shunting in a Large Cohort with Ischemic Priapism. Journal of Sexual Medicine. 2020; 17: 2472–2477.

[11] Broderick GA, Kadioglu A, Bivalacqua TJ, Ghanem H, Nehra A, Shamloul R. Priapism: pathogenesis, epidemiology, and management. Journal of Sexual Medicine. 2010; 7: 476–500.

[12] Johnson MJ, McNeillis V, Chiriaco G, Ralph DJ. Rare Disorders of Painful Erection: a Cohort Study of the Investigation and Management of Stuttering Priapism and Sleep-Related Painful Erection. Journal of Sexual Medicine. 2021; 18: 376–384.

[13] Silberman M, Stormont G, Hu EW. Priapism. Treasure Island (FL): StatPearls Publishing. 2021.

[14] Prattley S, Bryant T, Rees R. Superselective Embolization with Microcoil and Gelfoam for High-Flow Priapism Secondary to Bilateral Cavernous Fistulae: a Case Study. Case Reports in Urology. 2019; 2019: 1–4.

[15] Shigehara K, Namiki M. Clinical Management of Priapism: a Review. World Journal of Men’s Health. 2016; 34: 1–8.